Purpose: To assess the outcome of urologic evaluation in patients with voiding dysfunction due to multiple sclerosis (MS) and to determine the relationship between urological and neurological parameters of these patients.
INTRODUCTION
Multiple sclerosis (MS) is a common neurological disease affecting mostly young adults with a prevalence of 50 to 100/100,000 individuals (1). Regionally, the median estimated prevalence of MS is the highest in Europe (80 per 100 000), followed by the Eastern Mediterranean (14.9), the Americas (8.3) , -are common and severely disturb patient quality of life Neurourology (3). The reported incidence of voiding dysfunction is found in 33-52% of MS patients sampled consecutively regardless of urinary symptoms and its incidence is related to disability status (3-5). Several investigators have emphasized that the urodynamic assessment is essential for treating voiding dysfunction due to MS (6-9). Moreover, some authors have underlined that urodynamic evaluation should be repeated at regular intervals since the pattern of neurologic pathology and voiding dysfunction could change with time in MS patients. However, other authors have suggested management of the voiding dysfunction in MS, since upper tract deterioration was rare (10-12). The available data indicate that the high proportion of the detrusor overactivity with detrusorsphincter dyssynergia (DSD) is not associated with an increased risk for severe upper urinary tract deterioration (5,13-15). Hence, the evaluation and follow-up strategy in MS regarding the voiding dysfunction is still controversial. Furthermore, it was our clinical impression that complex urological investigations and follow-up strategy increased the management cost and had the side effect of increasing patient anxiety.
The aim of this study was to determine the outcome of urological evaluation in patients with voiding dysfunction due to MS referred to our urodynamic unit, and to assess the relationship between urological and disease related parameters including the disease activity, its duration, and expanded disability status scale in these patients.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of 249 consecutive patients (162 female and 87 male) with MS who had been referred to our urodynamic unit between 1991 and 2006, with a median time of 4 years (range 3 months to 26 years) of MS onset. The interval from the age at diagnosis of MS until the age at last neurourological evaluation was accepted as the disease duration. The clinical and demographic information about the neurological diagnosis, including the MS pattern (primary progressive, relapsing-remitting, or secondary progressive), the date of diagnosis, and score of expanded disability status scale (EDSS) was obtained from the patient disability status scale disease severity is scored from 0 to 10 at 0.5 point intervals (16) . the results of serum creatinine level, urinalysis (urine culture when necessary), urodynamic investigation -sidual urine volume determination) and urinary tract index. The symptom index score comprises storage (0-10) and voiding symptom index scores (0-12). Total symptom index score was calculated by adding the storage and voiding symptom index scores. The the total symptom index score on the questionnaire: mild-score lower than 7; moderate-score 8-14; severe-score 15-22. A nurse from the urodynamic evaluation form.
Upper urinary tract status was analyzed with respect to patient characteristics including age, gender, disease duration, MS pattern, EDSS score of MS, -tom index scores, and post-void residual volume.
Chi-square, Fisher's exact test, Mann-WhitCorrelation tests were performed for statistical analysis. The Chi-square test was used except in cases where the expected number of patients in any unit (or category) was less than 5, in which case the Fisher's exact test was used. We used the value of p < 0.05 as
RESULTS
The median age of patients during the initial urological evaluation was 38 years (range 8 to 68 years). Patient characteristics are outlined in Table-1. tract ultrasonography, 198 (79.5%) completed the Boyarsky symptom index and 75 (30.1%) were evaluated by urodynamic testing.
Median total, storage and voiding symptom scores in 198 evaluated by Boyarsky symptom score of 249 patients were 5, 3 and 1, respectively. All ex-185 symptomatic patients manifested mixed, storage, and voiding symptoms, respectively. Total, storage and voiding symptom scores weakly correlated with EDSS scores (p < 0.05) ( Table-2) .
Twelve patients (5%) had abnormal upper urinary tract, which were unilateral or bilateral hydrowere abnormal in 12 patients (5%), with thick bladder Voiding Dysfunction in Multiple Sclerosis -mographic parameter (age, gender, disease duration, MS pattern, or expanded disability MS status score) was associated with upper urinary tract abnormality on univariate analysis (Table-4). All patients who had unilateral or bilateral hydronephrosis remained stable with conservative management during the follow-up.
Urodynamic study performance rate gradually decreased from 100% to 13% during the period studied ( Figure-1 ). Urodynamic evaluation of 75 patients revealed detrusor overactivity in 26 (35%), detrusor overactivity with detrusor-sphincter dyssynergia in 30 (40%), detrusor overactivity with impaired contractility in 1 (1%), a poor compliance bladder in 7 was found between urodynamic diagnosis and upper urinary tract deterioration (p > 0.05) ( Table-4 ).
COMMENTS
In this series 70% of MS patients had mixed EDSS score. The rate of upper urinary tract deterioration was low (5%), and all patients were stable with conservative management. Although urodynamic -relation was found between upper tract deterioration and urodynamic abnormality. Since our study was retrospective, it may have limited implications. However, this study at least gives a clear message that prospective randomized studies are strongly needed in order to clarify the initial urologic evaluation, since there is no established protocol for this subject in the guidelines. This might lead to a decrease in management cost and patient anxiety.
reported, with a majority of women, as usually found in MS (3, 5, 7, 17, 18) . In our series 65% women and 42% of patients had a relapsing-remitting pattern of MS. This is quite comparable with the patients reported by Ciancio (68% women and 41% relaps--ings are typical and likely to be comparable to other authors.
The majority of our patients (185 of 198)
Department were referred to our clinic. In our study, the rates of mixed, storage and voiding symptoms results are similar to the reports from Western countries which revealed that storage symptoms such as urgency, frequency were the predominant urinary symptoms in MS (5,7). Araki et al. reported that voiding symptoms were equal to or higher than that of storage symptoms in Japan (19). However, in their detrusor sphincter dyssynergia were higher than our study and those reported from Western countries. When evaluating the relationship between neurologic and urologic abnormalities, we found a weak correlation between severity of EDSS and storage, voiding and total symptom scores. In some studies no correlation was found (20, 21) , whereas in others a direct correlation between EDSS score and storage and/or voiding score was reported (3, 8, 22) . Araki et al. found that storage symptoms correlated well with expanded disability status scale scores but -tion probably relates to the clinical course of MS which is characterized by exacerbations and remissions.
Multiple sclerosis is a disease with frequent -tion is rare. Many other studies including ours also showed that progression to upper tract deterioration in MS was usually the exception rather than the rule (1, 5, 12, 23 ). In the current series 5% of the patients had upper tract deterioration, although mild hydronephro- Table 3 lower urinary tract.
Abnormal Findings N (%)
Upper urinary tract Unilateral hydronephrosis Bilateral hydronephrosis contralateral mild Hydronephrosis 12 (5.2) 5 (2) 6 (2.6) 1 (0.4) Thick bladder wall Bladder diverticula 12 (5.2) 11 (4.7) 1 (0.5) sis was present in all except one patient. Koldewijn et al. reviewed 14 MS series of 2,076 patients regarding upper tract deterioration and found its incidence to be as low as 0.34% (5).
Meta analysis of 1,882 patients showed that overactivity and detrusor sphincter dyssynergia being (4) 142 (94) 76 (96) 0.756
Primary progressive (PP) Relapsing-remitting (RR) Secondary progressive (SP)
1 (2) 4 (4) 7 (8) 47 (98) 90 (96) 81 ( (92) 27 (90) - ( the most common (10,23). In contrast to detrusor sphincter dyssynergia in spinal cord injury, DSD in MS patients are rarely associated with upper tract deterioration while the reason for this is unclear (5, (23) (24) (25) (26) . It has been speculated that possibility of poorly sustained detrusor contractions and less severe degree of DSD in MS could be responsible for this distinction (23, 27) . Detrusor overactivity and detrusor sphincter dyssynergia were the most common urodynamic diagnoses in our study as in the previous studies, and risk factor for upper tract deterioration as in the study between the high proportion of detrusor overactivity/detrusor-sphincter dyssynergia and incidence al. investigated the risk factors for deterioration of upper tract and showed that no disease related or urodynamic parameters were predictive of abnormalities on renal ultrasonography. In addition, no patients in their series had any indication of obstructive uropathy more severe than mild stance in that only one of our patients had unilateral non-functional kidney. Moreover, our ratio of upper tract deterioration was found to be low and comparable to those in other series, which ranged between 0-25% (5, 14, 18, 23, 28) . In a recent study detrusor pressures between MS patients with and without DSD and observed non-significant elevations in detrusor pressures in both groups. This finding could explain the relatively low incidence of upper tract damage in patients with MS (15).
gradually decreased from 100% to 13% during the study period. Although our data is far from providing strong evidence for the overuse of urodynamic studies during initial urologic evaluation of MS patients, on the basis of the literature mentioned above and our increasing experience with MS patients this suggests that the multichannel urodynamic studies might be used only in the evaluation of patients with upper tract deterioration or with conservative treatment failure. We believe that this policy might lead to a decrease in the management cost and patient anxiety. A weakness of our study was that our data was collected retrospectively. However, the literature is fully supportive of our local data. Another potential weakness of our study is that we were not able to use a unique protocol for initial urologic evaluation of these patients, since there is no previously established protocol for this subject in the guidelines. Despite these limitations, we believe that our results provide a useful insight for clinicians when counseling patients with MS. 
CONCLUSIONS
The prevalence of mixed symptoms in patients with MS is higher than storage or voiding symptoms alone. Although detrusor overactivity and detrusor-sphincter dyssynergia were the most common urodynamic diagnoses, upper urinary tract deterioration was rare in this series. Prospective randomized studies are needed to clarify initial urologic evaluation for MS patients.
